1. Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer 
Semini Sumanasuriya, Aurelius Omlin, Andrew Armstrong, Gerhardt Attard, Kim N. Chi, Charlotte L. Bevan, Aki Shibakawa, Maarten J. IJzerman, Bram De Laere, Martijn Lolkema, David Lorente, Jun Luo, Niven Mehra, David Olmos, Howard Scher, Howard Soule, Nikolas H. Stoecklein, Leon W.M.M. Terstappen, David Waugh, Johann S. de Bono 
European Urology Oncology 
Volume 1, Issue 2, Pages (June 2018)
DOI: /j.euo
Copyright © 2018 European Association of Urology Terms and Conditions

2. Fig. 1
Expert voting on circulating biomarkers for advanced prostate cancer and their current utility in clinical practice. AR=androgen receptor; CNV=copy number variation; SNV=single-nucleotide variation; AR-V7=AR splice variant 7; cfDNA=cell-free DNA; CTC=circulating tumor cell.
European Urology Oncology 2018 1, DOI: ( /j.euo )
Copyright © 2018 European Association of Urology Terms and Conditions